Samuel M. Zentman's most recent trade in Klotho Neurosciences Inc. was a trade of 153,494 Common Stock done . Disclosure was reported to the exchange on Aug. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Klotho Neurosciences Inc. | Samuel M. Zentman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 153,494 | 736,440 | - | - | Common Stock | |
| Klotho Neurosciences Inc. | Samuel M. Zentman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2025 | 10,000 | 40,000 | - | - | Non-Qualified Stock Option |